ECD/SGT1 Antikörper (full length)
Kurzübersicht für ECD/SGT1 Antikörper (full length) (ABIN7878150)
Target
Alle ECD/SGT1 (ECD) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Güteklasse
Klon
-
-
Bindungsspezifität
- full length
-
Verwendungszweck
- ECD Antibody / SGT1 (azide and preservative free)
-
Aufreinigung
- Protein A/G affinity
-
Immunogen
- Recombinant full-length human protein was used as the immunogen for the ECD antibody.
-
Isotyp
- IgG2b
-
-
-
-
Applikationshinweise
- Optimal dilution of the ECD antibody should be determined by the researcher.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 mg/mL
-
Buffer
- 1 mg/mL in 1X PBS, BSA free, sodium azide free
-
Konservierungsmittel
- Azide free
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Aliquot the ECD antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
-
-
- ECD/SGT1 (ECD) (Ecdysoneless Homolog (ECD))
-
Andere Bezeichnung
- ECD
-
Hintergrund
- Inhibits MDM2-mediated degradation of p53/TP53 possibly by cooperating in part with TXNIP. May be involved transcriptional regulation. In vitro has intrinsic transactivation activity enhanced by EP300. May be a transcriptional activator required for the expression of glycolytic genes. Involved in regulation of cell cycle progression. Proposed to disrupt Rb-E2F binding leading to transcriptional activation of E2F proteins. The cell cycle -regulating function may depend on its RUVBL1-mediated association with the R2TP complex. May play a role in regulation of pre-mRNA splicing.
-
UniProt
- O95905
-
Pathways
- Regulation of Carbohydrate Metabolic Process
Target
-